Literature DB >> 19240545

Tube shunt complications and their prevention.

Steven R Sarkisian1.   

Abstract

PURPOSE OF REVIEW: Glaucoma drainage devices (GDDs) have been generally accepted as a treatment of refractory glaucoma. GDDs have their own unique set of complications that are important to evaluate to prevent them. RECENT
FINDINGS: Tube shunts are typically used in eyes with refractory glaucoma. There is increased interest in studying the efficacy of GDDs. Most of the attention has been focused on comparing trabeculectomy with the Baerveldt implant (Advanced Medical Optics, Inc., Santa Anna, California, USA). The other leading implant is the Ahmed Glaucoma Valve. There are several retrospective studies comparing these two devices and a prospective study is ongoing. There is great interest in the complication rate of tube shunts and these have been published both retrospectively and prospectively. Complications such as hypotony, diplopia, strabismus, proptosis, tube erosion, failure, corneal decompensation, endophthalmitis, and visual loss are all important and some have recently been reviewed in the literature. Moreover, the use of glaucoma drainage implants in the pediatric population has been evaluated.
SUMMARY: Glaucoma drainage implants have been a powerful tool in our surgical fight to prevent blindness; however, they are not without complications or controversy.

Entities:  

Mesh:

Year:  2009        PMID: 19240545     DOI: 10.1097/ICU.0b013e328323d519

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  29 in total

1.  Glaucoma drainage devices: risk of exposure and infection.

Authors:  Joshua D Levinson; Annette L Giangiacomo; Allen D Beck; Paul B Pruett; Hillary M Superak; Michael J Lynn; Anastasios P Costarides
Journal:  Am J Ophthalmol       Date:  2015-05-30       Impact factor: 5.258

Review 2.  Iatrogenic diplopia [corrected].

Authors:  Julio González-Martín-Moro; Julio José González-López; Marco Sales-Sanz; Andrea Sales-Sanz; Javier González-Martín-Moro; Fernando Gómez-Sanz; Mar González-Manrique; Belén Pilo-de-la-Fuente; Roberto García-Leal
Journal:  Int Ophthalmol       Date:  2014-03-07       Impact factor: 2.031

3.  Serial intracameral visualization of the Ahmed glaucoma valve tube by anterior segment optical coherence tomography.

Authors:  H-Y Lopilly Park; K I Jung; C K Park
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

4.  Diplopia in Medically and Surgically Treated Patients with Glaucoma.

Authors:  Philip Y Sun; David A Leske; Jonathan M Holmes; Cheryl L Khanna
Journal:  Ophthalmology       Date:  2016-11-18       Impact factor: 12.079

5.  Cyclodestructive procedures for refractory glaucoma.

Authors:  Monica F Chen; Carole H Kim; Anne L Coleman
Journal:  Cochrane Database Syst Rev       Date:  2019-03-10

6.  Effect of shunt type on rates of tube-cornea touch and corneal decompensation after tube shunt surgery in uveitic glaucoma.

Authors:  Sapna Sinha; Allen Y Ganjei; Melih Ustaoglu; Zeba A Syed; Daniel Lee; Jonathan S Myers; Scott J Fudemberg; Reza Razeghinejad
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-30       Impact factor: 3.117

Review 7.  [Subconjunctival minimally invasive glaucoma surgery : Methods and clinical results].

Authors:  M Lenzhofer; M Hohensinn; C Strohmaier; H A Reitsamer
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

8.  Scleral fixation of Ahmed glaucoma valve tube tip for adjustment of cornea-touching malposition.

Authors:  K T Ma; J H Kim; G J Seong; D S Jang; C Y Kim
Journal:  Eye (Lond)       Date:  2013-10-04       Impact factor: 3.775

9.  Tenon advancement and duplication technique to prevent postoperative Ahmed valve tube exposure in patients with refractory glaucoma.

Authors:  Nevbahar Tamcelik; Ahmet Ozkok; Ahmet Murat Sarıcı; Eray Atalay; Huseyin Yetik; Kivanc Gungor
Journal:  Jpn J Ophthalmol       Date:  2013-05-24       Impact factor: 2.447

10.  Ahmed glaucoma valve in children: A review.

Authors:  Nariman Nassiri; Kouros Nouri-Mahdavi; Anne L Coleman
Journal:  Saudi J Ophthalmol       Date:  2011-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.